Anne Heyes, MBA, a health economist with 20 years of clinical and commercial experience in the pharmaceutical industry, joined RTI Health Solutions (RTI-HS) as Head of Market Access-Europe. She will be based in our
Anne has extensive consulting experience and most recently was Director, Market Access at an international research and consulting organization. Her responsibilities included leading and managing the UK-based group, developing and implementing business strategies, business development and providing guidance on project delivery. Anne’s experience includes development of global and local market access strategies, creation of value dossiers, literature reviews, value-based communications, local submissions and utility studies.
Previously she was a Value Demonstration Leader at AstraZeneca where her primary role was the development and implementation of health economic and market access strategies for new products.
Anne has a BSc from Sheffield University and a Health Economics Diploma and MBA from Keele University.
“I am very excited to be at RTI-HS and to be working with such an enthusiastic group of experts. When I was in the pharmaceutical industry, RTI-HS was my favorite vendor because the staff always provided such high quality work and was a pleasure to collaborate with. I am very much looking forward to expanding RTI-HS’s success and building an attractive market access capability in Europe.”
About RTI Health Solutions
RTI Health Solutions provides scientifically rigorous research and consulting services in health economics, patient-reported outcomes, regulatory and health outcomes strategy, market access, health preference assessment, epidemiology, biostatistics, drug safety and pharmacovigilance, preclinical and clinical development to help biopharmaceutical companies successfully develop and gain market approval for their products.